A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity

NCT07639021 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

233

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: NNC0662-0419
DRUG: Semaglutide
DRUG: NNC0662-0419 Placebo
DRUG: Semaglutide placebo

Sponsor

Novo Nordisk A/S